Literature DB >> 15121848

Constitutive expression of tert in thymocytes leads to increased incidence and dissemination of T-cell lymphoma in Lck-Tert mice.

Andrés Canela1, Juan Martín-Caballero, Juana M Flores, María A Blasco.   

Abstract

Here we describe a new mouse model with constitutive expression of the catalytic subunit of telomerase (Tert) targeted to thymocytes and peripheral T cells (Lck-Tert mice). Two independent Lck-Tert mouse lines showed higher incidences of spontaneous T-cell lymphoma than the corresponding age-matched wild-type controls, indicating that constitutive expression of Tert promotes lymphoma. Interestingly, T-cell lymphomas in Lck-Tert mice were more disseminated than those in wild-type controls and affected both lymphoid and nonlymphoid tissues, while nonlymphoid tissues were never affected with lymphoma in age-matched wild-type controls. Importantly, these roles of Tert constitutive expression in promoting tumor progression and dissemination were independent of the role of telomerase in telomere length maintenance, since telomere length distributions on a single-cell basis were identical in Lck-Tert and wild-type thymocytes. Finally, Tert constitutive expression did not interfere with telomere capping in Lck-Tert primary thymocytes, although it resulted in greater chromosomal instability upon gamma irradiation in Lck-Tert primary lymphocytes than in controls, suggesting that Tert overexpression may interfere with the cellular response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121848      PMCID: PMC400466          DOI: 10.1128/MCB.24.10.4275-4293.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  31 in total

1.  Immature thymocytes employ distinct signaling pathways for allelic exclusion versus differentiation and expansion.

Authors:  F Gärtner; F W Alt; R Monroe; M Chu; B P Sleckman; L Davidson; W Swat
Journal:  Immunity       Date:  1999-05       Impact factor: 31.745

2.  Telomerase contributes to tumorigenesis by a telomere length-independent mechanism.

Authors:  Sheila A Stewart; William C Hahn; Benjamin F O'Connor; Elisa N Banner; Ante S Lundberg; Poonam Modha; Hana Mizuno; Mary W Brooks; Mark Fleming; Drazen B Zimonjic; Nicholas C Popescu; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-22       Impact factor: 11.205

Review 3.  Telomeres and cancer: a tale with many endings.

Authors:  María A Blasco
Journal:  Curr Opin Genet Dev       Date:  2003-02       Impact factor: 5.578

4.  Telomerase modulates expression of growth-controlling genes and enhances cell proliferation.

Authors:  Laura L Smith; Hilary A Coller; James M Roberts
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

5.  Shortened telomeres join to DNA breaks interfering with their correct repair.

Authors:  Laura Latre; Laura Tusell; Marta Martin; Rosa Miró; Josep Egozcue; María A Blasco; Anna Genescà
Journal:  Exp Cell Res       Date:  2003-07-15       Impact factor: 3.905

6.  Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression.

Authors:  Sandy Chang; Christine M Khoo; Maria L Naylor; Richard S Maser; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-01-01       Impact factor: 11.361

7.  hTERT associates with human telomeres and enhances genomic stability and DNA repair.

Authors:  Girdhar G Sharma; Arun Gupta; Huichen Wang; Harry Scherthan; Sonu Dhar; Varsha Gandhi; George Iliakis; Jerry W Shay; Charles S H Young; Tej K Pandita
Journal:  Oncogene       Date:  2003-01-09       Impact factor: 9.867

Review 8.  Evolving views of telomerase and cancer.

Authors:  Maria A Blasco; William C Hahn
Journal:  Trends Cell Biol       Date:  2003-06       Impact factor: 20.808

9.  Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase.

Authors:  K E Chaffin; C R Beals; T M Wilkie; K A Forbush; M I Simon; R M Perlmutter
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

10.  Developmental regulation of lck gene expression in T lymphocytes.

Authors:  R S Wildin; A M Garvin; S Pawar; D B Lewis; K M Abraham; K A Forbush; S F Ziegler; J M Allen; R M Perlmutter
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

View more
  26 in total

1.  Telomerase can act as a template- and RNA-independent terminal transferase.

Authors:  Neal F Lue; Dimitry Bosoy; Tara J Moriarty; Chantal Autexier; Brian Altman; Siyang Leng
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-30       Impact factor: 11.205

Review 2.  Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins.

Authors:  Paula Martínez; María A Blasco
Journal:  Nat Rev Cancer       Date:  2011-03       Impact factor: 60.716

Review 3.  Molecular Insights Into Pathogenesis of Peripheral T Cell Lymphoma: a Review.

Authors:  Waseem Lone; Aisha Alkhiniji; Jayadev Manikkam Umakanthan; Javeed Iqbal
Journal:  Curr Hematol Malig Rep       Date:  2018-08       Impact factor: 3.952

Review 4.  Mice with bad ends: mouse models for the study of telomeres and telomerase in cancer and aging.

Authors:  María A Blasco
Journal:  EMBO J       Date:  2005-03-10       Impact factor: 11.598

5.  The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression.

Authors:  María Luisa Cayuela; Juana M Flores; María A Blasco
Journal:  EMBO Rep       Date:  2005-03       Impact factor: 8.807

6.  The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence.

Authors:  Bruno Bernardes de Jesus; Kerstin Schneeberger; Elsa Vera; Agueda Tejera; Calvin B Harley; Maria A Blasco
Journal:  Aging Cell       Date:  2011-04-14       Impact factor: 9.304

7.  TELOMERASE ACTIVATOR1 induces telomerase activity and potentiates responses to auxin in Arabidopsis.

Authors:  Shuxin Ren; J Spencer Johnston; Dorothy E Shippen; Thomas D McKnight
Journal:  Plant Cell       Date:  2004-10-14       Impact factor: 11.277

8.  A dominant interfering Bub1 mutant is insufficient to induce or alter thymic tumorigenesis in vivo, even in a sensitized genetic background.

Authors:  Dale O Cowley; Ginger W Muse; Terry Van Dyke
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 9.  Telomerase at the intersection of cancer and aging.

Authors:  Bruno Bernardes de Jesus; Maria A Blasco
Journal:  Trends Genet       Date:  2013-07-19       Impact factor: 11.639

Review 10.  A 'higher order' of telomere regulation: telomere heterochromatin and telomeric RNAs.

Authors:  Stefan Schoeftner; Maria A Blasco
Journal:  EMBO J       Date:  2009-07-23       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.